BFC Planning’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
CF
MBAM
BFC Planning's HCAT Position: Q3 2026 in Review
BFC Planning held its Health Catalyst (HCAT) position steady in Q3 2026 at 1,000 shares worth $1.73K. The position accounts for ﹤0.01% of the portfolio, ranked #3044.
BFC Planning first reported a position in HCAT in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.99K in Q2 2026. 76 funds tracked by Wall St. Rank hold HCAT as of Q3 2026.
- BFC Planning held 1,000 shares of Health Catalyst worth $1.73K as of Q3 2026.
- BFC Planning left its Health Catalyst share count unchanged in Q3 2026.
- Health Catalyst made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3044 holding.
- BFC Planning first reported a position in Health Catalyst in Q2 2025 and has held it in 5 quarters since.
- BFC Planning's Health Catalyst position peaked at $1.99K in Q2 2026.
- 76 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.